# A Study of Evolocumab on Carotid Artery Atherosclerotic Plaque Morphology Prior to Carotid EndArterectomy

> **NCT04539223** · PHASE4 · UNKNOWN · sponsor: **Canadian Medical and Surgical Knowledge Translation Research Group** · enrollment: 60 (estimated)

## Conditions studied

- Carotid Artery Stenosis
- Asymptomatic Carotid Artery Stenosis

## Interventions

- **DRUG:** Evolocumab

## Key facts

- **NCT ID:** NCT04539223
- **Lead sponsor:** Canadian Medical and Surgical Knowledge Translation Research Group
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08-28
- **Primary completion:** 2022-04
- **Final completion:** 2022-05
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-05-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04539223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04539223, "A Study of Evolocumab on Carotid Artery Atherosclerotic Plaque Morphology Prior to Carotid EndArterectomy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04539223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*